1
|
Negi S and Anand A: Atherosclerotic
coronary heart disease-epidemiology, classification and management.
Cardiovasc Hematol Disord Drug Targets. 10:257–261. 2010.
View Article : Google Scholar : PubMed/NCBI
|
2
|
Murray CJ and Lopez AD: Mortality by cause
for eight regions of the world: Global burden of disease study.
Lancet. 349:1269–1276. 1997. View Article : Google Scholar
|
3
|
Rosamond W, Flegal K, Friday G, et al;
American Heart Association Statistics Committee and Stroke
Statistics Subcommittee. Heart disease and stroke statistics - 2007
update: a report from the American Heart Association Statistics
Committee and Stroke Statistics Subcommittee. Circulation.
115:e69–e171. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Mi X, Eskridge KM, George V and Wang D:
Structural equation modeling of gene-environment interactions in
coronary heart disease. Ann Hum Genet. 75:255–265. 2011.PubMed/NCBI
|
5
|
Kullo IJ and Ding K: Mechanisms of
disease: The genetic basis of coronary heart disease. Nat Clin
Pract Cardiovasc Med. 4:558–569. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Marsden PA, Heng HH, Scherer SW, et al:
Structure and chromosomal localization of the human constitutive
endothelial nitric oxide synthase gene. J Biol Chem.
268:17478–17488. 1993.PubMed/NCBI
|
7
|
Shimasaki Y, Yasue H, Yoshimura M, et al:
Association of the missense Glu298Asp variant of the endothelial
nitric oxide synthase gene with myocardial infarction. J Am Coll
Cardiol. 31:1506–1510. 1998. View Article : Google Scholar : PubMed/NCBI
|
8
|
Li J, Wu X, Li X, Feng G, He L and Shi Y:
The endothelial nitric oxide synthase gene is associated with
coronary artery disease: a meta-analysis. Cardiology. 116:271–278.
2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhang K, Bai P, Shi S, et al: The G894T
polymorphism on endothelial nitric oxide synthase gene is
associated with increased coronary heart disease among Asia
population: evidence from a Meta analysis. Thromb Res. 130:192–197.
2012. View Article : Google Scholar
|
10
|
Moher D, Liberati A, Tetzlaff J and Altman
DG; PRISM Group. Preferred reporting items for systematic reviews
and meta-analyses: the PRISMA statement. PLoS Med. 6:e10000972009.
View Article : Google Scholar
|
11
|
Borenstein M, Hedges L, Higgins J,
Rothstein H and Englewood NJ: Comprehensive meta-analysis: A
computer program for meta-analysis. Biostat Inc; 2007, [Computer
software].
|
12
|
Higgins JP and Thompson SG: Quantifying
heterogeneity in a meta-analysis. Stat Med. 21:1539–1558. 2002.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Higgins JP, Thompson SG, Deeks JJ and
Altman DG: Measuring inconsistency in meta-analyses. BMJ.
327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Egger M, Davey Smith G, Schneider M and
Minder C: Bias in meta-analysis detected by a simple, graphical
test. BMJ. 315:629–634. 1997. View Article : Google Scholar : PubMed/NCBI
|
15
|
Duval S and Tweedie R: Trim and fill: A
simple funnel-plot-based method of testing and adjusting for
publication bias in meta-analysis. Biometrics. 56:455–463. 2000.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Yoshimura M, Yasue H, Nakayama M, et al: A
missense Glu298Asp variant in the endothelial nitric oxide synthase
gene is associated with coronary spasm in the Japanese. Hum Genet.
103:65–69. 1998. View Article : Google Scholar : PubMed/NCBI
|
17
|
Cai H, Wilcken DE and Wang XL: The
Glu-298→Asp (894G→T) mutation at exon 7 of the endothelial nitric
oxide synthase gene and coronary artery disease. J Mol Med (Berl).
77:511–514. 1999.
|
18
|
Hingorani AD, Liang CF, Fatibene J, et al:
A common variant of the endothelial nitric oxide synthase
(Glu298→Asp) is a major risk factor for coronary artery disease in
the UK. Circulation. 100:1515–1520. 1999.
|
19
|
Poirier O, Mao C, Mallet C, et al:
Polymorphisms of the endothelial nitric oxide synthase gene - no
consistent association with myocardial infarction in the ECTIM
study. Eur J Clin Invest. 29:284–290. 1999. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yoon Y, Song J, Hong SH and Kim JQ: Plasma
nitric oxide concentrations and nitric oxide synthase gene
polymorphisms in coronary artery disease. Clin Chem. 46:1626–1630.
2000.PubMed/NCBI
|
21
|
Yoshimura M, Yasue H, Nakayama M, et al:
Genetic risk factors for coronary artery spasm: significance of
endothelial nitric oxide synthase gene T-786-->C and missense
Glu298Asp variants. J Investig Med. 48:367–374. 2000.PubMed/NCBI
|
22
|
Granath B, Taylor RR, van Bockxmeer FM and
Mamotte CD: Lack of evidence for association between endothelial
nitric oxide synthase gene polymorphisms and coronary artery
disease in the Australian Caucasian population. J Cardiovasc Risk.
8:235–241. 2001. View Article : Google Scholar
|
23
|
Wang CL, Hsu LA, Ko YS, Ko YL and Lee YH:
Lack of association between the Glu298Asp variant of the
endothelial nitric oxide synthase gene and the risk of coronary
artery disease among Taiwanese. J Formos Med Assoc. 100:736–740.
2001.PubMed/NCBI
|
24
|
Colombo MG, Andreassi MG, Paradossi U, et
al: Evidence for association of a common variant of the endothelial
nitric oxide synthase gene (Glu298→Asp polymorphism) to the
presence, extent, and severity of coronary artery disease. Heart.
87:525–528. 2002.PubMed/NCBI
|
25
|
Wei D, Shan J, Chen Z and Shi Y: The G894T
mutation of the endothelial nitric oxide synthase gene is
associated with coronary atherosclerotic heart disease in Chinese.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 19:471–474. 2002.(In
Chinese).
|
26
|
Chang K, Baek SH, Seung KB, et al: The
Glu298Asp polymorphism in the endothelial nitric oxide synthase
gene is strongly associated with coronary spasm. Coron Artery Dis.
14:293–299. 2003. View Article : Google Scholar : PubMed/NCBI
|
27
|
Colombo MG, Paradossi U, Andreassi MG, et
al: Endothelial nitric oxide synthase gene polymorphisms and risk
of coronary artery disease. Clin Chem. 49:389–395. 2003. View Article : Google Scholar : PubMed/NCBI
|
28
|
Afrasyap L and Ozturk G: NO level and
endothelial NO synthase gene polymorphism (Glu298Asp) in the
patients with coronary artery disease from the Turkish population.
Acta Biochim Biophys Sin (Shanghai). 36:661–666. 2004. View Article : Google Scholar : PubMed/NCBI
|
29
|
Agema WR, de Maat MP, Zwinderman AH, et
al: An integrated evaluation of endothelial constitutive nitric
oxide synthase polymorphisms and coronary artery disease in men.
Clin Sci (Lond). 107:255–261. 2004. View Article : Google Scholar : PubMed/NCBI
|
30
|
Cam SF, Sekuri C, Tengiz I, et al: The
G894T polymorphism on endothelial nitric oxide synthase gene is
associated with premature coronary artery disease in a Turkish
population. Thromb Res. 116:287–292. 2005. View Article : Google Scholar : PubMed/NCBI
|
31
|
Jaramillo PC, Muñoz MA, Lanas MC, Lanas ZF
and Salazar LA: Endothelial nitric oxide synthase G894T gene
polymorphism in Chilean subjects with coronary artery disease and
controls. Clin Chim Acta. 371:102–106. 2006. View Article : Google Scholar : PubMed/NCBI
|
32
|
Kerkeni M, Addad F, Chauffert M, et al:
Hyperhomocysteinemia, endothelial nitric oxide synthase
polymorphism, and risk of coronary artery disease. Clin Chem.
52:53–58. 2006. View Article : Google Scholar : PubMed/NCBI
|
33
|
Ji XW, Zhang AY and Guan LX: Association
between angiotensin-converting enzyme and endothelial nitric oxide
synthase gene polymorphism and risk of coronary artery disease.
Zhonghua Xin Xue Guan Bing Za Zhi. 35:1024–1028. 2007.(In
Chinese).
|
34
|
Kim IJ, Bae J, Lim SW, et al: Influence of
endothelial nitric oxide synthase gene polymorphisms (−786T>C,
4a4b, 894G>T) in Korean patients with coronary artery disease.
Thromb Res. 119:579–585. 2007.
|
35
|
Wang ZL, Zhao YQ, Liao JD, et al:
Association of endothelial nitric oxide synthase gene polymorphism
with level of uric acid in serum for acute coronary syndrome.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 19:652–656. 2007.(In
Chinese).
|
36
|
Mathew J, Narayanan P, Sundaram R, et al:
Lack of association between Glu(298) asp polymorphism of
endothelial nitric oxide synthase (eNOS) gene and coronary artery
disease in Tamilian population. Indian Heart J. 60:223–227.
2008.PubMed/NCBI
|
37
|
Tamemoto H, Ishikawa SE and Kawakami M:
Association of the Glu298Asp polymorphism of the eNOS gene with
ischemic heart disease in Japanese diabetic subjects. Diabetes Res
Clin Pract. 80:275–279. 2008. View Article : Google Scholar : PubMed/NCBI
|
38
|
Vasilakou M, Votteas V, Kasparian C, et
al: Lack of association between endothelial nitric oxide synthase
gene polymorphisms and risk of premature coronary artery disease in
the Greek population. Acta Cardiol. 63:609–614. 2008. View Article : Google Scholar
|
39
|
Zakrzewski-Jakubiak M, de Denus S, Dubé
MP, Bélanger F, White M and Turgeon J: Ten renin-angiotensin
system-related gene polymorphisms in maximally treated Canadian
Caucasian patients with heart failure. Br J Clin Pharmacol.
65:742–751. 2008. View Article : Google Scholar : PubMed/NCBI
|
40
|
Alp E, Menevse S, Tulmac M, et al: Lack of
association between matrix metalloproteinase-9 and endothelial
nitric oxide synthase gene polymorphisms and coronary artery
disease in Turkish population. DNA Cell Biol. 28:343–350. 2009.
View Article : Google Scholar
|
41
|
Alkharfy KM, Al-Daghri NM, Al-Attas OS,
Alokail MS, Draz HM and Hussain T: Endothelial nitric oxide
synthase gene polymorphisms (894G > T and −786T > C) and risk
of coronary artery disease in a Saudi population. Arch Med Res.
41:134–141. 2010.
|
42
|
Angeline T, Isabel W and Tsongalis GJ:
Endothelial nitric oxide gene polymorphisms, nitric oxide
production and coronary artery disease risk in a South Indian
population. Exp Mol Pathol. 89:205–208. 2010. View Article : Google Scholar : PubMed/NCBI
|
43
|
Bor-Kucukatay M, Demir S, Akbay R,
Dursunoglu D, Akdag B and Semiz E: Relationship between
hemorheology and Glu(298)Asp polymorphism of endothelial nitric
oxide synthase gene in patients with coronary artery disease. Mol
Biol Rep. 37:171–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
44
|
Isordia-Salas I, Leaños-Miranda A and
Borrayo-Sánchez G: The Glu298ASP polymorphism of the endothelial
nitric oxide synthase gene is associated with premature ST
elevation myocardial infarction in Mexican population. Clin Chim
Acta. 411:553–557. 2010. View Article : Google Scholar : PubMed/NCBI
|
45
|
Salimi S, Firoozrai M, Zand H, et al:
Endothelial nitric oxide synthase gene Glu298Asp polymorphism in
patients with coronary artery disease. Ann Saudi Med. 30:33–37.
2010.PubMed/NCBI
|
46
|
Velloso MW, Pereira SB, Gouveia L, et al:
Endothelial nitric oxide synthase Glu298Asp gene polymorphism in a
multi-ethnical population with heart failure and controls. Nitric
Oxide. 22:220–225. 2010. View Article : Google Scholar : PubMed/NCBI
|
47
|
Motawi T, Shaker O, Taha M, Sedrak H and
Nabil M: Endothelial nitric oxide synthase and angiotensinogen gene
polymorphism in coronary artery diseases in Egypt. Angiology.
62:191–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
48
|
Saini V, Bhatnagar MK and Bhattacharjee J:
Association of endothelial dysfunction with endothelin, nitric
oxide and eNOS Glu298Asp gene polymorphism in coronary artery
disease. Dis Markers. 31:215–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
49
|
da Costa Escobar Piccoli J, Manfredini V,
Hamester FI, et al: Interaction between endothelial nitric oxide
synthase gene polymorphisms (−786T>C, 894G>T and intron 4
a/b) and cardiovascular risk factors in acute coronary syndromes.
Arch Med Res. 43:205–211. 2012.
|
50
|
Gad MZ, Abdel Rahman MF, Hashad IM,
Abdel-Maksoud SM, Farag NM and Abou-Aisha K: Endothelial nitric
oxide synthase (G894T) gene polymorphism in a random sample of the
Egyptian population: comparison with myocardial infarction
patients. Genet Test Mol Biomarkers. 16:695–700. 2012. View Article : Google Scholar : PubMed/NCBI
|
51
|
Rahimi Z and Nourozi-Rad R: Association of
endothelial nitric oxide synthase gene variant (G894T) with
coronary artery disease in Western Iran. Angiology. 63:131–137.
2012. View Article : Google Scholar : PubMed/NCBI
|
52
|
Rai H, Fitt J, Sharma AK, et al: Lack of
association between Glu298Asp polymorphism and coronary artery
disease in North Indians. Mol Biol Rep. 39:5995–6000. 2012.
View Article : Google Scholar : PubMed/NCBI
|
53
|
Superko HR, Roberts R, Agatston A, et al:
Genetic testing for early detection of individuals at risk of
coronary heart disease and monitoring response to therapy:
challenges and promises. Curr Atheroscler Rep. 13:396–404. 2011.
View Article : Google Scholar : PubMed/NCBI
|
54
|
Devuyst O: Variable renal disease
progression in autosomal dominant polycystic kidney disease: a role
for nitric oxide? J Nephrol. 16:449–452. 2003.PubMed/NCBI
|
55
|
Takaoka M: NOS gene polymorphism. Nihon
Rinsho. 62:103–109. 2004.(In Japanese).
|
56
|
León-Velarde F and Mejía O: Gene
expression in chronic high altitude diseases. High Alt Med Biol.
9:130–139. 2008.
|
57
|
Su MT, Lin SH and Chen YC: Genetic
association studies of angiogenesis- and vasoconstriction-related
genes in women with recurrent pregnancy loss: a systematic review
and meta-analysis. Hum Reprod Update. 17:803–812. 2011. View Article : Google Scholar : PubMed/NCBI
|